A policy that will require domestic manufacturers of surgical masks to emboss them with the letters "MD" and "MIT" will take effect Sept. 24, one week later than planned, to allow for logistical adjustments, the CECC said Wednesday.
When the policy takes effect, all surgical masks pre-ordered through the National Health Insurance (NHI) system will carry the imprint "MD" (Medical Device) and "MIT" (Made in Taiwan), the CECC said.
Taiwan's Food and Drug Administration (FDA) said the new policy would start Sept. 17 in a bid to prevent fraud, but the statement was retracted later in the day without any explanation. Domestically-manufactured masks should be imprinted with "MD" and "MIT" since Sept. 24. From Sept. 25, masks without the letters "MD" and "MIT" will be banned. Therefore, domestically produced masks that do not have the imprint must be recalled by March 23, 2021, after which they must be certified by local health authorities before they can be put on sale again, the CECC added.
Detailed information on the regulations can be accessed on 西藥、醫療器材及化粧品許可證查詢系統.
